Mourabit Halima, Author at MediaMedic

EHA Expert Interview | Professor Zhiming Li: Zanubrutinib Combined with CHOP Shows Superior Efficacy in Newly Diagnosed DLBCL Patients, Especially in the GCB Subtype

By Mourabit Halima 2025.03.05

In the treatment of diffuse large B-cell lymphoma (DLBCL), the R-CHOP regimen has been a cornerstone, but enhancing its efficacy remains a significant challenge in the medical community. At the…

EHA Expert Interview | Professors Huilai Zhang and Shiyong Zhou’s Team: Major Advances in Lymphoma Research

By Mourabit Halima 2025.03.05

The 29th European Hematology Association (EHA) Annual Meeting was grandly held in Madrid, Spain, from June 13-16, 2024. As the largest international conference in the field of hematology in Europe,…

EHA Expert Interview | Professor Jie Jin: Zhejiang University’s Voice Resonates Internationally with GR1803 for RRMM

By Mourabit Halima 2025.03.05

The 29th European Hematology Association (EHA) Annual Meeting took place from June 13-16, 2024, in Madrid, Spain. As Europe's largest international event in the field of hematology, the meeting attracts…

Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer

By Mourabit Halima 2025.03.05

Xinghai Forum: Professors Yang Zhang and Kejing Zhang Discuss CDK4/6 Inhibitors in Adjuvant Therapy for HR+ Breast Cancer Editor's Note: Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have brought transformative breakthroughs to…

HNF1A Genotype & HCC Risk | Dr. Mohamed Abdel Samiee

By Mourabit Halima 2025.03.05

EASL Liver Cancer Summit 2025 | Professor Abdel Ghani Badran on Ultrasound Elastography for Early HCC Detection

By Mourabit Halima 2025.03.05

EHA 2024: Transforming Insights into Action for Better Patient Outcomes

By Mourabit Halima 2025.03.04

As we reflect on EHA 2024, the impact of this year’s congress continues to resonate within the hematology community. The groundbreaking research, innovative treatment strategies, and expert discussions presented at…

EHA 2024: Bridging Research and Practice to Elevate Hematology Care

By Mourabit Halima 2025.03.04

From clinical trials to real-world applications, the EHA Congress has bridged the gap between research and practice, enhancing the standard of care for hematological patients. #EHA2024 #BridgingTheGap

A Doctor’s Battle Against Cancer: A Story of Hope and Innovation

By Mourabit Halima 2025.03.04

An extraordinary story that shines a light on the remarkable advances in cancer treatment and the power of innovative research.Professor Richard Scolyer, co-director of the Melanoma Institute Australia, was faced…

Research Team from Beijing Chaoyang Hospital Unveils a New Mechanism Linking Double-Negative T Cells to Fatty Liver Disease Progression

By Mourabit Halima 2025.03.04

A research team led by Dr. Dong Zhang and Dr. Guangyong Sun from Beijing Chaoyang Hospital, Capital Medical University, in collaboration with Dr. Zhongtao Zhang from Beijing Friendship Hospital, Capital…